-
Diagnostics World News | An interdisciplinary team of researchers at The Ohio State University (OSU) is creating a “new paradigm for personalized medicine” with a skin gas sensing device for monitoring metabolism and managing weight.
May 5, 2022
-
Diagnostics World News | Over the next few years, pharmacogenomics could start to become a standard component of clinical care to improve drug efficacy and avoid adverse responses when certain medicines are prescribed.
May 3, 2022
-
Diagnostics World | Funding for AI in disease detection and non-invasive brain diagnostics, immune-oncology cancer therapeutics, tissue therapeutics, and more.
Apr 29, 2022
-
Diagnostics World News | New genomics efforts in Brazil, HPV variant tests, COVID-19 virus and antibody tests, pre-term birth prediction by RNA profiling, metabolomics-based diagnostics, high-plex spatial imaging, blood-based glycoproteomics, new device for detecting mild cognitive impairment, and an award for rapid infection diagnostics.
Apr 28, 2022
-
Diagnostics World | Researchers in Australia played a leading role in development of a DNA-based test to catch what short-read Illumina sequencing often misses: long and repetitive genetic variants implicated in about 40 late-onset neurodegenerative and neuromuscular conditions. These highly complex short tandem repeat (STR) expansion disorders, which have proven difficult to profile with any technology, can now be handily diagnosed with Oxford Nanopore Technology (ONT).
Apr 26, 2022
-
Diagnostics World | At the height of the Omicron surge this winter, at-home rapid tests and PCR testing were hard to come by for everyone, but especially people with low-incomes, non-native English speakers, and immigrant communities. Along with more eligible people being vaccinated, an affordable, accessible NAAT test for the masses is the most effective way to live with the virus rather than being dominated by it again.
Apr 22, 2022
-
Diagnostics World | A Stanford team led by Euan Ashley, professor of medicine, genetics and biomedical data science, sequenced a patient’s genome in a snappy five hours and two minutes on a PromethION platform from Oxford Nanopore, an achievement ratified by the Genome in a Bottle Consortium of the National Institute of Science and Technology.
Apr 20, 2022
-
Diagnostics World | A blood test to help clinicians diagnose Alzheimer’s disease is “on the road” to effectively replacing cerebrospinal fluid (CSF) testing and PET scans for detecting Alzheimer’s pathology, according to Randall J. Bateman, M.D., a professor of neurology at Washington University School of Medicine and co-developer of the plasma protein assay. A commercial version of the test, PrecivityAD, is already being used extensively in clinical trials as well to evaluate patients in real-world settings.
Apr 19, 2022